The percentage of CD66b+CD33dimHLA-DR− cells in PBMCs from lymphoma patients at diagnosis correlates with prognostic index scores, freedom from disease progression (FFDP) and disease status. The gene discussed is CEACAM8; the disease is lymphoma.